8 research outputs found
Determination of proteins, lipids and carbohydrates in the most frequently consumed fish in the Canary Islands
16 pages, 13 figures, 1 tablePeer Reviewe
A comparison of primary care physicians and pneumologists in the management of asthma in Spain: ASES study
Kinetics of metabolic pathways. Transient response of the glycolytic system after phosphofructokinase reaction to ADP input
Transition state of the glycolytic pathway under fdp saturating conditions: Experimental studies and a theoretical model
Los árboles, l'ocalitu y Ñuberu. 'Los árboles, el eucalipto y Ñuberu'
Fecha tomada del código del documentoPartiendo del libro del mismo título, los profesores del Seminario de Llingua Asturiana de la comarca del Nalón, realizan unas diapositivas de las ilustraciones y textos del mismo, así como una grabación de éstos con el alumnado de asturiano de los diversos colegios. Del mismo modo, elaboraran una unidad didáctica de este área en la que las diapositivas, la lectura del libro y la salida para conocer los árboles del entorno sirven como motivación para el desarrollo de las actividades de comprensión y expresión de lengua asturiana propuestas.AsturiasES
Perfil de un paciente con enfermedad obstructiva crónica tratado con la combinación de un agonista β2 adregénico de acción prolongada y un corticoide inhalado en un dispositivo presurizado en la práctica clínica habitual: estudio ARIES
Resumen: Objetivo: el objetivo del estudio fue describir el perfil epidemiológico, clínico y calidad de vida de los pacientes con enfermedad pulmonar obstructiva crónica, estables, en tratamiento de mantenimiento con un agonista β2 adrenérgico de acción prolongada y un corticoide inhalado (LABA/ICS) en un mismo dispositivo presurizado (pMDI). Materiales y métodos: estudio observacional, multicéntrico, transversal en práctica clínica habitual, realizado en 50 centros en España. Se evaluaron 390 pacientes ≥ 40 años, en tratamiento con LABA/ICS en un pMDI durante al menos los 3 meses anteriores a la inclusión. Datos demográficos y clínicos recogidos de la historia clínica y la respuesta al cuestionario COPD Assessment Test. Resultados: los pacientes analizados en el estudio fueron mayoritariamente varones (71,3%); un 73,4% de los pacientes distribuidos en una puntuación de ausencia de comorbilidad o comorbilidad baja; un 84,9% en grupos GOLD 2-3; 32,6 y 38,2% de los participantes con un grado de disnea 1 y 2 según la escala modificada Medical Research Council, respectivamente. La puntuación media en el cuestionario COPD Assessment Test fue de 16,3 (8,4). Conclusiones: el perfil de los pacientes en tratamiento de mantenimiento con LABA/ICS en un pMDI es mayoritariamente varones, con ausencia o bajo nivel de comorbilidades, gravedad funcional moderada-grave y disnea leve-moderada. Los pacientes informaron un impacto medio de su calidad de vida. Abstract: Background and objective: The study aimed to describe the profile of patients with stable chronic obstructive pulmonary disease (COPD) and maintenance treatment with a long-acting beta2-adrenergic agonist and an inhaled corticosteroid (LABA/ICS) in a pressurised device (pMDI), and to assess the quality of life (HRQoL). Materials and methods: Observational, multicentre, cross-sectional study in routine clinical practice, conducted in 50 sites in Spain. 390 patients aged ≥ 40 years, treated with LABA/ICS in a pMDI device for at least the previous 3 months before the inclusion, were assessed. Demographic and clinical data were collected from medical records and patient-reported COPD Assessment Test (CAT). Results: The patients analysed in the study were mostly male (71.3%); 84.9% in GOLD 2-3 groups; and 32.6% and 38.2% of participants with dyspnoea grade 1 and 2 according to the modified Medical Research Council (mMRC) scale, respectively. The mean CAT questionnaire score (standard deviation [SD]) was 16.3 (8.4). Conclusions: The profile of the patients treated with LABA/ICS in a pMDI device is mainly male, with no or low comorbidities, moderate-severe functional severity, and mild-moderate dyspnoea. Patients reported a medium impact on their quality of life
CAPPRIC Study—Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings
The real burden of community-acquired pneumonia (CAP) in non-hospitalized patients is largely unknown. This is a 3-year prospective, observational study of ambulatory CAP in adults, conducted in 24 Spanish primary care centers between 2016–2019. Sociodemographic and clinical variables of patients with radiographically confirmed CAP were collected. Pneumococcal etiology was assessed using the Binax Now® test. Patients were followed up for 10 ± 3 days. A total of 456 CAP patients were included in the study. Mean age was 56.6 (±17.5) years, 53.5% were female, and 53.9% had ≥1 comorbidity. Average incidence of CAP was 1.2–3.5 cases per 1000 persons per year. Eighteen patients (3.9%) were classified as pneumococcal CAP. Cough was present in 88.1% of patients at diagnosis and fever in 70.8%. Increased pulmonary density (63.3%) and alveolar infiltrates with air bronchogram (16.6%) were the most common radiographic findings. After 14.6 ± 6.0 days (95% CI = 13.9–15.3), 65.4% of patients had recovered. Hospitalization rate was 2.8%. The most frequently prescribed antibiotics were quinolones (58.7%) and β-lactams (31.1%). In conclusion, one-third of CAP patients did not fully recover after two weeks of empiric antibiotic therapy and 2.8% required hospitalization, highlighting the significant burden associated with non-hospitalized CAP in Spain
CAPPRIC Study-Characterization of Community-Acquired Pneumonia in Spanish Adults Managed in Primary Care Settings.
The real burden of community-acquired pneumonia (CAP) in non-hospitalized patients is largely unknown. This is a 3-year prospective, observational study of ambulatory CAP in adults, conducted in 24 Spanish primary care centers between 2016-2019. Sociodemographic and clinical variables of patients with radiographically confirmed CAP were collected. Pneumococcal etiology was assessed using the Binax Now® test. Patients were followed up for 10 ± 3 days. A total of 456 CAP patients were included in the study. Mean age was 56.6 (±17.5) years, 53.5% were female, and 53.9% had ≥1 comorbidity. Average incidence of CAP was 1.2-3.5 cases per 1000 persons per year. Eighteen patients (3.9%) were classified as pneumococcal CAP. Cough was present in 88.1% of patients at diagnosis and fever in 70.8%. Increased pulmonary density (63.3%) and alveolar infiltrates with air bronchogram (16.6%) were the most common radiographic findings. After 14.6 ± 6.0 days (95% CI = 13.9-15.3), 65.4% of patients had recovered. Hospitalization rate was 2.8%. The most frequently prescribed antibiotics were quinolones (58.7%) and β-lactams (31.1%). In conclusion, one-third of CAP patients did not fully recover after two weeks of empiric antibiotic therapy and 2.8% required hospitalization, highlighting the significant burden associated with non-hospitalized CAP in Spain